Antitumor, antibiotic and antileishmanial properties of the pyranonaphthoquinone psychorubrin from Mitracarpus frigidus

Anais da Academia Brasileira de Ciencias

Volumn 84, Issue 4, 2012, Pages 1081-1089

  Fabri, Rodrigo L ^a   Grazul, Richard M ^a   De Carvalho, Lidiane O ^a   Coimbra, Elaine S ^a   Cardoso, Gabriele M M ^b   De Souza Fagundes, Elaine M ^b   Da Silva, Adilson D ^a   Scio, Elita ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Mitracarpus frigidus; Psychorubrin; Pyranonaphthoquinone; Rubiaceae

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; NAPHTHOQUINONE; PSYCHORUBRIN;

ARTICLE; CHEMISTRY; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IC 50; ISOLATION AND PURIFICATION; LEISHMANIA; MICROBIAL SENSITIVITY TEST; RUBIACEAE; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIPROTOZOAL AGENTS; CELL LINE, TUMOR; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA; MICROBIAL SENSITIVITY TESTS; NAPHTHOQUINONES; RUBIACEAE;

FILOBASIDIELLA NEOFORMANS; FUNGI; MITRACARPUS; MITRACARPUS FRIGIDUS; RUBIACEAE;

EID: 84870876933     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/S0001-37652012005000064     Document Type: Article

References (34)

1. ARRUDA RCO and GOMES DMS. 1996. Anatomia foliar de Mitracarpus frigidus (Wild.) K. Schum. var. salzmannianus (DC) K. Schum. e Mitracarpus lhorzkianus Cham (Rubiaceae), São Paulo: Herbarium Bradeanum, 14 p.
2. BISIGNANO G, SANOGO R, MARINO A, AQUINO R, D'ANGELO V, GERMANO MP, DE PASQUALE R, and PIZZA C. 2000. Antimicrobial activity of Mitracarpus scaber extract and isolated constituents. Lett Applied Microbiol 30: 105-108.
3. BRAGA FG, BOUZADA MLM, FABRI RL, MATOS MO, MOREIRA FO, SCIO E and COIMBRA ES. 2007. Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol 111: 396-402.
4. BULBULE VJ, KORANNE PS, MUNOT YS, BORATE HB and DESHPANDE VH. 2003. Simple synthesis of two naphthoquinone antibiotics psychorubrin and pentalongin. Synthetic Commun 33: 587-594.
5. EKPENDU TOE, ADESOMOJU AA and OKOGUN JI. 2001. Chemical studies of Mitracarpus villosus (Sw.) DC - a medicinal rubiaceous weed. J Chem Soc Nigeria 26: 69-74.
6. FABRI RL, NOGUEIRA MS, BRAGA FG, COIMBRA ES and SCIO E. 2009. Mitracarpus frigidus aerial parts exhibited potent antimicrobial, antileishmanial, and antioxidant effects. Bioresource Technol 100: 428-433.
7. FOTAKIS G and TIMBRELL JA. 2006. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160: 171-177.
8. GBAGUIDI F, ACCROMBESSI G, MOUDACHIROU M and Quetin-Leclercq J. 2005. HPLC quantification of two isomeric triterpenic acids isolated from Mitracarpus scaber and antimicrobial activity on Dermatophilus congolensis. J Pharm Biomed Anal 39: 990-995.
9. GREFF D. 1998. Cosmetic and pharmaceutical compositions for beautifying and lightening skin containing Mitracarpus extracts. PCT Int Appl WO 9805299.
10. HAROUNA H, FAURE R, ELIAS R, DEBRAUWERM L, SAADOU M, BALANSARD G and BOUDON G. 1995. Harounoside a pentalongin hydroquinone diglycoside from Mitracarpus scaber. Phytochemistry 39: 1483-1484.
11. HAYASHI T, SMITH FT and LEE KH. 1987. Antitumor agents. 89. Psychorubrin, a new cytotoxic naphthoquinone from Psychotria rubra and its structure-activity relationships. J Med Chem 30: 2005-2008.
12. JACOBS J, CLAESSENS S and DE KIMPE N. 2008. First straightforward synthesis of 1-hydroxy-3,4-dihydro-1H- benz[g]isochromene-5,10-dione and structure revision of a bioactive benz[g]isochromene-5,10-dione from Psychotria camponutans. Tetrahedron 64: 412-418.
13. KESTELEYN B, DE KIMPE N and VAN PUYVELDE L. 1999. Synthesis of two naphthoquinone antibiotics pentalongin and psychorubrin. Synthesis 11: 1881-1883.
14. KRISHNAN P and BASTOW KF. 2000. Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives eleutherin, α-lapachone, and β-lapachone. Biochem Pharmacol 60: 1367-1379.
15. LEE H, HONG SS and KIM YH. 1996. Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones. Bioorg Med Chem Lett 6: 933-936.
16. LI W, LAM MS, BIRKELAND A, RIFFEL A, MONTANA L, SULLIVAM ME and Post JM. 2006. Cell-based assays for profiling acticity and safety properties of cancer drugs. J Pharmacol Toxicol Methods 54: 313-319.
17. M'BONGO N, LOISEAU P, LAWRENCE F, BORIES C, CRACIUNESCU DG and Robert-Gero M. 1997. In vitro sensivity of Leishmania donovani to organometallic derivatives of pentamidine. Parasitol Res 83: 515-517.
18. MONKS A, SCUDIERO D, SKEHAN P, SHOEMAKER R, PAULL K, VISTICA D, HOSE C, LANGLEY J, CRONISE P and Vaigro-Wolff A. 1991. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer I 83: 757-766.
19. MOSMANN T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol Methods 65: 55-63.
20. nd International Congress on Ethnopharmacology, July 2-4, 1992, Uppsala, Sweden.
21. NAGATA S. 2000. Apoptotic DNA fragmentation. Exp Cell Res 256: 12-18.
22. NCCLS - NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2 - P. National Committee for Clinical Laboratory Standards. Wayne, PA.
23. NGUYEN VT and DE KIMPE N. 2004. Synthesis of pyranonaphthoquinone antibiotics involving the ring-closing metathesis of vinyl ether. Tetrahedron Lett 45: 3443-3446.
24. NICOLETTI I, MIGLIORATIM G, PAGLIACCIM MC, GRIGNANIM F and RICCARDI C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279.
25. OKUNADE AL, CLARK AM, HUFFORD CD and OGUNTIMEIN BO. 1999. Azaanthraquinone: an antimicrobial alkaloid from Mitracarpus scaber. Planta Med 65: 447-448.
26. PEREZ C, PAULI M and BAZERQUEM P. 1990. An antibiotic assay by the well agar method. Acta Biol Med Exp 15: 113-115.
27. PERFECT JR and CASADEVALL A. 2002. Cryptococcosis. Infect Dis Clin North Am 16: 837-874.
28. SANCHEZ LM, LOPEZ D, VESELY BA, TOGNA GD, GERWICK WH, KYLE DE and LININGTON RG. 2010. Almiramides A-C: Discovery and Development of a New Class of Leishmaniasis Lead Compounds. J Med Chem 53: 4187-4197.
29. SPINDLER R and URBANEC SJ. 2009. Improved skin brightening compositions. PCT Int. Appl. WO 2009/099911.
30. nd ed., London: Academic, 282 p.
31. TSUJI D and NAKANISHI H. 2010. Skin-conditioning compositions containing fucoxanthin and hydroquinone derivative and cosmetics, skin-lightening compositions, and cosmetic creams containing them. JP 2010/209023.
32. VAN DER HORST CM et al. 1997. Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome. N Engl J Med 337: 15-21.
33. WANG W, LI T, MILBURN R, YATES J, HINNANT E, LUZZIO MJ, NOBLE SA and ATTARDO G. 1998. Novel 1,3-disubstituted-5,10-dihydro-5,10-dioxo-1H-mbenzo[g] isochromene-3-carboxamides as potent antitumor agents. Bioorg Med Chem Lett 8: 1579-1584.
34. YANG W, HU B, SUN J, ZHAI S and DONALD H. 2010. Death mode-dependent reduction in succinate dehydrogenase activity in hair cells of aging rat cochleae. Chin Med J 123: 1633-1638.